Recent Insider Buying in Biotech and Healthcare Stocks


BIOTECH
Martek Biosciences [MATK]: September 11-12, $20-$21 by CEO and Director
Pharacyclics [PCYC]: Jan-Sep 2006, $3.50-$4.80 by Director and Beneficial Owner
Replidyne [RDY]: Aug-Sep 2006, $10 by Director
Nutrition 21 [NXXI]: Sep 14, $1.76 by CFO

DRUGS
Novogen [NVGN]: May-Sep 2006, $9-$12 by Beneficial Owner
GTX [GTXI]: Sep8-12, $9.00-$9.50 by Director
Iomai [IOMI]: Sep8-12, $3.88-$4.15 by Director

MEDICAL SUPPLIES
CryoCor [CRYO]: Sep13, $3.12 by Officer
Emerging Vision [ISEE]: Jun 2005 - Sep 2006, $0.10-$0.15 by Director